Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N06DA03	EXELON TRANSDERMAL PATCH 15	B	Rivastigmine - 13.3mg/24h	13.3mg/24h	Patch	7,582,922 L.L
N06DA03	RIVASTIGMINE ARROW	G	Rivastigmine - 1.5mg	1.5mg	Capsule	684,016 L.L
N06DA03	RIVASTIGMINE ARROW	G	Rivastigmine - 1.5mg	1.5mg	Capsule	684,016 L.L
B01AF01	XARELTO	B	Rivaroxaban - 20mg	20mg	Tablet, film coated	4,440,862 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B01AF01	RIXALTA 20	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,164,664 L.L
B01AF01	VAROXA	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	952,208 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B01AF01	XARELTO	B	Rivaroxaban - 2.5mg	2.5mg	Tablet, film coated	4,045,168 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 2.5mg	2.5mg	Tablet, film coated	3,199,625 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	2,015,764 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B01AF01	XARELTO	B	Rivaroxaban - 15mg	15mg	Tablet, film coated	4,440,862 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B01AF01	RIXALTA 15	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,164,664 L.L
B01AF01	VAROXA	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	952,208 L.L
B01AF01	XARELTO	B	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,588,892 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	959,888 L.L
B01AF01	RIXALTA 10	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	671,921 L.L
B01AF01	VAROXA	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	2,879,854 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	606,649 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,439,255 L.L
L01FA01	MABIXEN 500	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrate for solution	136,761,210 L.L
L01FA01	MABIXEN 500	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrate for solution	74,718,320 L.L
L01FA01	MABTHERA	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrated solution	80,211,932 L.L
L01FA01	RITUXIREL	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrated solution	45,258,360 L.L
L01FA01	RIXATHON	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrate for solution	66,951,899 L.L
L01FA01	RITUXIREL	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrated solution	L.L

...

189